loadpatents
Patent applications and USPTO patent grants for Jordaan; Pierre.The latest application filed is for "treatment of autoimmune disease in a patient receiving additionally a beta-blocker".
Patent | Date |
---|---|
Treatment Of Autoimmune Disease In A Patient Receiving Additionally A Beta-blocker App 20220008385 - Legangneux; Eric ;   et al. | 2022-01-13 |
Treatment Of Autoimmune Disease In A Patient Receiving Additionally A Beta-blocker App 20200383947 - Legangneux; Eric ;   et al. | 2020-12-10 |
Treatment Of Autoimmune Disease In A Patient Receiving Additionally A Beta-blocker App 20190038599 - Legangneux; Eric ;   et al. | 2019-02-07 |
Treatment Of Autoimmune Disease In A Patient Receiving Additionally A Beta-blocker App 20180042895 - Legangneux; Eric ;   et al. | 2018-02-15 |
Treatment Of Hypertension And/or Prevention Or Treatment Of Heart Failure In A Mammal Receiving Anti-coagulant Therapy App 20140329872 - Albrecht; Diego Jochen ;   et al. | 2014-11-06 |
Treatment Of Hypertension And/or Prevention Or Treatment Of Heart Failure In A Mammal Receiving Anti-coagulant Therapy App 20130158088 - Albrecht; Diego ;   et al. | 2013-06-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.